A2 Refereed review article in a scientific journal

Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?




AuthorsLaurila Sanna, Rebelos Eleni, Honka Miikka-Juhani, Nuutila Pirjo

PublisherFrontiers in Endocrinology

Publication year2021

JournalFrontiers in Endocrinology

Journal acronymFront. Endocrinol.

Volume12

DOIhttps://doi.org/10.3389/fendo.2021.737686

Web address https://www.frontiersin.org/article/10.3389/fendo.2021.737686

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/67265386


Abstract

Secretin is the first hormone that has been discovered, inaugurating the era and the field of endocrinology. Despite the initial focus, the interest in its actions faded away over the decades. However, there is mounting evidence regarding the pleiotropic beneficial effects of secretin on whole-body homeostasis. In this review, we discuss the evidence from preclinical and clinical studies based on which secretin may have a role in the treatment of obesity.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 22:05